经皮穴位电刺激联合揿针用于剖宫产术后镇痛的有效性:一项随机对照试验
本研究纳入100例择期剖宫产产妇,随机分为针灸组与假针灸组,针灸组接受术前及术中经皮穴位电刺激联合术后揿针治疗。结果显示针灸组48小时累计吗啡消耗量中位数低于假针灸组,差异有统计学意义,且术后6、12、24小时疼痛评分更低、满意度更高、恶心呕吐发生率更低。
要点
- 经皮穴位电刺激联合揿针可显著降低剖宫产术后48小时累计吗啡消耗量。
- 该联合方案可降低术后6、12、24小时静息及运动疼痛评分。
- 该方案安全性良好,未报告针灸相关不良反应,并降低术后恶心呕吐发生率。
核心结论
- 经皮穴位电刺激联合揿针作为非药物辅助镇痛方式,可安全有效地减少剖宫产术后吗啡消耗并缓解疼痛,推荐作为产后镇痛的常规补充治疗。
研究设计与样本
- 本研究为随机对照试验,纳入100例在腰硬联合麻醉下择期剖宫产的足月单胎孕妇,随机分为针灸组(n=50)和假针灸组(n=50)。
主要发现
- 针灸组48小时累计吗啡消耗量中位数(四分位距)为22.9(16.9-28.9)mg,低于假针灸组的34.9(22.4-39.4)mg,估计中位数差为-10.0 mg(95%CI [-14.0, -4.0];P < 0.001)。
- 广义估计方程分析显示,针灸组在术后6、12、24小时的累计吗啡消耗量均显著低于假针灸组(P < 0.001)。
- 针灸组在术后6、12、24小时的静息及运动疼痛评分均低于假针灸组(P < 0.001),患者满意度更高(P < 0.001)。
- 针灸组术后恶心呕吐发生率为12%,低于假针灸组的30%(P = 0.03),且研究期间未报告任何针灸相关不良反应。
关键数值与推荐
- 主要结局为48小时累计吗啡消耗量,针灸组中位数22.9 mg,假针灸组34.9 mg,中位数差-10.0 mg(95%CI [-14.0, -4.0];P < 0.001)。
- 术后恶心呕吐发生率针灸组12% vs 假针灸组30%(P = 0.03)。
临床怎么用
- 对于择期剖宫产产妇,可考虑在术前及术中实施经皮穴位电刺激、术后联合揿针治疗,作为多模式镇痛的非药物补充手段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Optimizing analgesia following caesarean section is essential for improving maternal rehabilitation and fostering maternal-infant bonding. OBJECTIVE: The purpose of this study was to evaluate the safety and effectiveness of transcutaneous electrical acupoint stimulation (TEAS) combined with press needle therapy as an adjunctive approach for postoperative pain control following caesarean section. DESIGN, SETTING, PARTICIPANTS AND INTERVENTIONS: One hundred women with singleton term pregnancies who were schedule to undergo caesarean section births under combined spinal-epidural anesthesia were recruited. Patients were randomly assigned to the acupuncture group (n = 50) or sham-acupuncture group (n = 50). The acupuncture group received pre- and intraoperative TEAS combined with postoperative press needle therapy. The sham-acupuncture group received a sham acupuncture intervention. MAIN OUTCOME MEASURES: The primary outcome was total cumulative morphine consumption at 48 h. Secondary outcomes included pain scores, morphine consumption and patient satisfaction. Analgesic-related adverse effects and acupuncture-related side effects were recorded. RESULTS: Overall, 100 patients were included in the intention-to-treat analysis. Median (interquartile range) of cumulative morphine consumption at 48 h in the acupuncture group was lower than that in the sham-acupuncture group (22.9 [16.9-28.9] mg vs 34.9 [22.4-39.4] mg), with an estimated median difference of -10.0 mg (95% confidence interval, [-14.0, -4.0]; P < 0.001). The generalized estimating equation analysis also revealed that cumulative morphine consumption was significantly lower in the acupuncture group than in the sham-acupuncture group at 6, 12 and 24 h (P < 0.001). In addition, patients in the acupuncture group reported lower pain scores both at rest and during movement at 6, 12 and 24 h compared to those in the sham-acupuncture group (P < 0.001). Furthermore, acupuncture improved patient satisfaction (P < 0.001) and decreased the incidence of nausea and vomiting after surgery (12% vs 30%; P = 0.03). None of the patients in the study experienced any acupuncture-related side effects. CONCLUSION: As a non-pharmacological approach, TEAS combined with press needle therapy safely and effectively reduced postoperative morphine consumption and alleviated postoperative pain in women who underwent caesarean sections, recommending it as a routine complementary treatment for postpartum analgesia. TRIAL REGISTRATION: The protocol was registered at the Chinese Clinical Trial Registry (ChiCTR2400086645). Please cite this article as: Qin PP, Wei K, Zou BY, Liu D, Li MX, Liu XN, Zou L, Wu B. Effectiveness of transcutaneous electrical acupoint stimulation combined with press needle therapy for pain control after caesarean section: A randomized controlled trial. J Integr Med. 2026; 24(4):542-548.
引用
- Qin PP, Wei K, Zou BY, et al. Effectiveness of transcutaneous electrical acupoint stimulation combined with press needle therapy for pain control after caesarean section: A randomized controlled trial. J Integr Med. 2025. PMID: 41339168. doi:10.1016/j.joim.2025.10.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。